Merck & Co Inc (NYSE:MRK)

110.19
Delayed Data
As of Nov 30
 +1.35 / +1.24%
Today’s Change
71.50
Today|||52-Week Range
110.33
+43.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$272.6B

Company Description

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Contact Information

Merck & Co., Inc.
2000 Galloping Hill Road
Kenilworth New Jersey 07033
P:(908) 740-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders39.11%
Other institutional37.25%
Individual stakeholders0.14%

Top Executives

Robert M. DavisPresident, Chief Executive Officer & Director
Caroline A. LitchfieldChief Financial Officer & Executive Vice President
Dave WilliamsEVP, Chief Information & Digital Officer
Lisa LeCointe-CephasChief Ethics & Compliance Officer, SVP
Richard R. DeLucaExecutive Vice President & President-Animal Health